28 Jan Update: Phenylephrine – Lack of Effectiveness of Oral Preparations as Nasal Decongestant
Posted at 20:41h
in
This document is intended to communicate with the Holders of Certificates of Registration (HCRs) of orally administered phenylephrine-containing medicines.
Following the communication issued to stakeholders on 30 July 2024 regarding the ineffectiveness of oral phenylephrine preparations as nasal decongestants, HCRs for orally administered phenylephrine-containing medicines were given 90 days to respond, as outlined in the communication.
Download latest version
Document Number:
CLINPR03-2024/25
Version:
1
Date Updated:
28/01/2025
File Type:
pdf
Category:
Communication to industry